To examine differences in the spectral power content in neonates diagnosed with congenital diaphragmatic hernia (CDH) who survive or succumb.
INTRODUCTION
The incidence of congenital diaphragmatic hernia (CDH) is 0.3 per 1000 live births. 1 The associated significant perinatal mortality is related to the underlying pulmonary hypoplasia and severe pulmonary hypertension. The overall survival rate for those managed at a tertiary center with interventions such as highfrequency ventilation and extracorporeal membrane oxygenation (ECMO) prior to surgical correction, although improved from a decade ago, is only 63%. 1 Over the years, many predictors of outcome have been suggested. Sonographic parameters of the fetus have included early diagnosis, 2 polyhydramnios, 2 intrathoracic stomach, 3 mediastinal shift, visceral herniation, 4 and quantification of the contralateral lung area. 5 A very promising prognostic indicator, that of ''liverup'' vs ''liver-down'', predicted 75 to 80% survival in the ''liverdown'' group. 6 The newly developed lung-to-head ratio, most reliable when combined with the presence or absence of liver herniation, appears to have more success in the ''liver-up'' vs the ''liver-down'' CDH. 1, 7 Controversy continues to exist regarding the predictive value of these parameters and requires further study in the clinical arena.
Postnatal criteria used to predict mortality have included Apgar scores, 8 blood gas values, 9 lung-to-thorax transverse ratios, 10 functional residual capacity, 11 logistic regression formulae that include Apgar scores, birth weight, ventilatory index, and best preoperative PaCO 2, 12 as well as a recent mathematical quantity using left ventricular mass and fractional shortening as calculated by echocardiographic measurements. 13 For almost 25 years, research has consistently documented the positive relationship between heart rate variability (HRV) and clinical outcome. [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] HRV is the cumulation of integrated activity of autonomic neurons as generated by cardiopulmonary reflexes. Thus, monitoring HRV may provide valuable information regarding the neonate's response or lack of response to therapies. We could locate no articles that measured HRV continuously, while the neonate was undergoing ECMO. Therefore, the purpose of the study is to determine whether a frequency-based evaluation of the cardiac signal of four neonates diagnosed with CDH, two who received ECMO support, may be a sensitive prognosticator of outcome.
MATERIALS AND METHODS
The convenience sample for this case study series was obtained from a larger investigation that had the primary aim of describing changes in the variability of heart rate, respiratory rate, blood pressure, and oxygen saturation in healthy and compromised neonates transitioning to extrauterine life. The work had been approved by the Committee for the Protection of Human Subjects, and informed consent had been obtained from the baby's parents for inclusion in the study.
Subjects: Four neonates diagnosed with CDH (Table 1) were compared to determine similarities/differences in HRV in the two who received ECMO therapy vs the two that did not.
Instrumentation: The HR signal was obtained through the standard placement of the electrocardiograph leads and was uploaded from a Hewlett-Packard Viridia cardiopulmonary monitor to a data acquisition module at the bedside that initialized the hardware, digitized the signal, and stored it in a binary file at a rate of 1000 samples per second. The data were analyzed using custom-designed software on the LabVIEW platform to determine locations of R-wave peaks, thus yielding the interbeat intervals. Missed peaks or extra peaks resulting from errors in this detection process were filled in or removed, as appropriate in each instance, by using a multiple timescale statistical filter. The resulting signal was processed to remove the 10-s, centered moving average that removed the slow changes in level and the dc power. The clean signal obtained after filtration was then inspected to pick out time intervals that were relatively stationary; these were used for computation of the power spectrum. These intervals contained 625 points each, which corresponds to 4 minutes and 10 seconds at 150 beats/per minute. This length was chosen so that the frequency resolution in the power spectrum is better than 0.04 Hz.
Data analysis: Data analysis was implemented with Fortran 90 programs tailored for our needs. A periodogram was used to compute the power spectrum. The interbeat intervals were naturally nonuniformly sampled in time since each interval length varied from its neighboring one and the time stamp cannot be uniformly spaced. Lomb's algorithm, 32 used widely in astrophysics, is particularly appropriate for computing the power spectrum for such nonuniformly sampled data sets. 33 The power spectrum was integrated in two frequency bands to yield convenient measures of power in the slowly varying parts of the signal and the rapidly varying parts that are likely to be in the range of respiratory frequencies. The low-frequency band, 0.04 to 0.30 Hz, is influenced by both the sympathetic and parasympathetic nervous systems (PSNS). The high-frequency band, 0.3 to 1.8 Hz, is influenced by the PSNS, with the resultant spectral energies often referred to as vagal tone. Sum of the power in the two bands gives the total power content, and values of the total power or band powers are expressed in log units that result from taking the natural logarithm of the raw power values. Note that the raw power values are always positive, but the logarithm can occasionally lead to negative values for the power. Specifically, the logarithm is negative when the raw power is between 0 and 1. Figure 1 depicts the alterations in spectral energies during illness and/or recovery throughout the subjects' hospital stay. Subject 160, a sick preterm baby with CDH, was not placed on ECMO due to the severity of the diaphragmatic defect and his birth weight of 1800 g. He required such intensive, constant medical and nursing interventions that the captured data for the first hour of life were too complicated with artefact; thus, the spectral energies are reported only for the fifth hour. This baby was managed medically with paralysis and ventilatory management, and succumbed at approximately 20 hours of life. Although the power in the highfrequency band, À0.91, is almost four times greater than that in the lower, À2.26, it is still very small. It may also be argued that this is a false increase in the proportion of HF power due to the effect of the mechanical ventilator, referred to in the literature as artificial RSA. The conventional ventilator rate was initially set at 60 breaths/minute; however, due to the baby's deteriorating Verklan and Padhye Heart Rate Variability condition, he was later placed on a high-frequency oscillator with the rate set at 9 Hz and an amplitude set at 50. The very low amount of power across the frequency bandwidths is indicative of a loss of PSNS influence, or vagal tone, reflective of continuing/ worsening neurophysiologic stress. Subjects 171 and 175, both diagnosed with CDH, demonstrated decreased spectral energies in both the LF and HF bandwidths once ECMO had been discontinued. Baby 171, initially managed with conventional ventilation, required increasing cardiopulmonary support over the first 3 days, including nitric oxide, pressors, and a switch to high-frequency oscillation. From day of life (DOL) 1 until time she was placed on ECMO at DOL 4, there was a consistent decrease in the spectral energies across all bandwidths (Figure 1 ). This is in keeping with a withdrawal of vagal tone (PSNS power delineated in the HF bandwidth), as well as a decrease in sympathetic nervous system power. Data obtained on DOLs 4, 6, 9, 12, 15, 24, 27, 32, and 36 reflect the HRV while undergoing ECMO. Maximal support was necessary to support her physiologically for the majority of her life. At the times it was thought that her condition had improved, she underwent a ''trial off'' of ECMO. Subject 171 failed to recover and required an increase in ECMO support when she was placed back on the intervention at DOL 24. Figure 1 eloquently displays the decreased and negative log power values in the spectral bandwidths at these times of increased physiologic stress. Clinically, there were no obvious discerning changes in the blood pressure or heart rate that indicated a rapid decompensation. She died a day after the measurement obtained on DOL 42.
RESULTS
Subject 175, a sick full-term neonate with CDH, required ECMO support within the first 6 hours of life (Figure 1 ). Pleural effusions necessitated chest tubes placed to suction at 12 to 15 cm of water pressure on the day of birth and DOL 1. Poststabilization, the power steadily increases in both the LF and HF bands until the baby is removed from ECMO. The power across all bands after that remains extremely low, with very little vagal tone as well as little sympathetic nervous system input. The baby died shortly after DOL 21.
Subject 176, a full-term neonate with CDH simply required minimal-to-moderate conventional ventilatory support (Figure 1 ). Once the surgical repair was completed on DOL 2, there was a fairly consistent gain in energies across the bandwidths so that by time of discharge the total power was greatly increased, with 70% of the power contained in the HF bands. Despite feeding difficulties related to reflux, the predominance of vagal tone indicates neurophysiologic stability. The role of vagal tone in the maintenance of physiologic homeostasis and the reactivity of the sympathetic system as a defense mechanism has been proposed as one means of assessing the stress vulnerability of the compromised individual. 34, 35 At 8 months of age, she continues to thrive and do well.
Babies with CDHs, both preterm and full term, who survived had log total power values greater than 2, and demonstrated a consistent increasing trend (Figure 2 ). Those babies with CDH who did not survive had log total power values of less than 2; however, while supported with ECMO, their log total power values were generally greater than 3. The reader will have noticed that subjects 171 and 175 exhibited increased total power just before succumbing, and this issue is addressed in the next section. The preterm baby with CDH who was not supported by ECMO had an extremely decreased log total power value of almost À1.
SIGNIFICANCE
Babies presenting with CDH display a wide range of symptomatology. Treatment modalities are focused on optimizing gas exchange and treating PPHN; however, lability remains a constant challenge to healthcare providers. The prediction of mortality in the infant diagnosed with CDH remains difficult. Evaluation of HRV has the potential to discern signs of stress as documented by alterations in the power spectrum that are not measurable with traditional bedside cardiopulmonary monitoring.
Babies who consistently displayed increasing total spectral energies had a better outcome than those whose spectral energies were low. Neonates whose defects were not as severe demonstrated a more consistent increase in the log total power values whether supported by ECMO or not. Exhibiting a log total power greater than 2 indicated physiologic stability for all subjects. Further study will be needed to determine whether the value may be useful as an indicator of neurophysiologic stress.
The subjects with the greatest defects, 171 and 175, expressed the lowest values, especially once support from ECMO was withdrawn. They had very little reserves to draw upon, and surrendered quickly to respiratory failure. Both neonates displayed increases in spectral energies, most notable in the high-frequency band, shortly before they died (Figure 1 ). Critical care clinicians often remark about a ''flame out'' phenomenon whereby the baby's vital signs seem to undergo somewhat of an improvement such that the baby may appear to be at their physiologic ''best'' in the 12 to 48 hours or so preceding death. It has been suggested that the improvement may be due to the last surge of catecholamine, glycogen, or any reserves the body may have left. It would be very interesting to explore this phenomenon by adding laboratory data to the clinical evidence. There is a profound need for the development of a neurophysiologic assessment tool that can evaluate an individual's responses to medical interventions. Measuring fluctuations of spectral power in the frequency bandwidths provides an assessment of vagal tone, and indirectly, the amount of physiologic stress the baby is experiencing. The advantage of this approach to monitoring is that, unlike electrocardiographic changes, neither cardiac disease nor metabolic derangement significantly alters the control mechanisms creating these oscillatory patterns. 34 We have presented data that suggest that a frequency-based evaluation of the cardiac signal in a neonate with CDH may be a sensitive prognosticator of outcome.
